July 12, 2021
July 12, 2021 – The U.S. FDA has approved a new indication for Janssen’s Darzalex Faspro® (daratumumab/
hyaluronidase-fihj) to be used in combination with pomalidomide
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
July 9, 2021
July 9, 2021 – The U.S. FDA has approved Kerendia® (finerenone), manufactured by Bayer, to reduce the
risk of sustained eGFR decline
July 9, 2021
July 9, 2021 – The U.S. FDA has approved a new indication for Padcev® (enfortumab vedotin-ejfv), manufactured by Seagen
July 2, 2021
July 2, 2021 – The U.S. FDA has approved an expanded indication for Merck’s Bridion® (sugammadex),
which is used to reverse neuromuscular blockade induced by rocuronium
July 1, 2021
July 1, 2021 – Merck will voluntarily withdraw an indication for Keytruda® (pembrolizumab) to
July 1, 2021
July 1, 2021 – The U.S. FDA has approved a new indication for Solosec® (secnidazole) oral granules,
manufactured by Lupin Pharmaceuticals
July 1, 2021
July 1, 2021 – The U.S. FDA has approved a new indication for Noxafil® (posaconazole – Merck)
intravenous (IV) injection and delayed-release oral tablets
July 1, 2021
July 1, 2021 – The U.S. FDA has approved an expanded indication for ArmonAirTM RespiClick® (fluticasone propionate) oral inhalation powder, manufactured by Teva. The drug, which